🇺🇸 FDA

Drug profile · INN

brivaracetam

BRIVIACT (IN ITALY: NUBRIVEO)

approved N03AX23
US status
approved
Patents linked
0
News articles
0

Quick answer

brivaracetam (BRIVIACT (IN ITALY: NUBRIVEO)) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN brivaracetam
Brand BRIVIACT (IN ITALY: NUBRIVEO)
Route ORAL
Formulation SOLUTION
ATC code N03AX23
Originator Sunshine Biopharma

Frequently asked questions

What is brivaracetam?

brivaracetam (BRIVIACT (IN ITALY: NUBRIVEO)) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for brivaracetam?

BRIVIACT (IN ITALY: NUBRIVEO) is a marketed brand name for brivaracetam. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of brivaracetam?

brivaracetam has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.